Amplo
ActiveOverview
Amplo is a global venture capital firm founded in 2017 that invests in early-stage companies across fintech, healthtech, artificial intelligence, and other technology-driven sectors. The firm focuses on supporting entrepreneurs building globally ambitious companies at pre-seed, seed, and Series A stages, providing both capital and strategic guidance to portfolio companies. Amplo is known for backing notable companies including Robinhood, Parsley Health, and Andela.
History
Amplo was founded in 2017 by Sheel Tyle with a mission to support entrepreneurs building impactful, globally ambitious companies. The firm established itself as a seed and Series A investor across multiple industries including fintech, healthtech, and artificial intelligence. Over its operational period, Amplo has built a portfolio of successful companies and expanded its team with experienced venture partners and advisors.
Product Lines
| Product Line | Positioning | Price Range |
|---|---|---|
| Pre-Seed Investment | Early-stage capital for concept-stage companies | $50,000 - $500,000 |
| Seed Stage Investment | Growth capital for validated business models | $500,000 - $2,000,000 |
| Series A Investment | Expansion capital for scaling companies | $2,000,000 - $10,000,000 |
| Strategic Advisory Services | Guidance and mentorship for portfolio companies | Included with investment |
Manufacturing
As a venture capital firm, Amplo does not manufacture physical products. The firm operates as an investment and advisory service provider, deploying capital into portfolio companies and offering strategic guidance to support their growth and development.
Notable Products
- Robinhood Investment - Early-stage investment in the fintech platform that democratized retail investing
- Parsley Health Investment - Investment in the digital health company focused on preventive and personalized medicine
- Andela Investment - Investment in the talent network connecting African developers with global opportunities
Reputation
Amplo is regarded as a thoughtful early-stage investor with a focus on impact-driven companies rather than purely financial returns. The firm is recognized for its experienced team and strong advisory network that provides value beyond capital. While specific criticisms are not widely documented, the firm operates in a competitive venture capital landscape where success is measured by portfolio company outcomes and returns over time.